Skip to main content
MEDIANA Co.,LTD logo

MEDIANA Co.,LTD — Investor Relations & Filings

Ticker · 041920 ISIN · KR7041920000 KO Manufacturing
Open in API
Filings indexed 199 across all filing types
Latest filing 2020-10-26 Earnings Release
Country KR South Korea
Listing KO 041920

About MEDIANA Co.,LTD

http://www.mediana-global.com/

Mediana Co., Ltd. is a medical device company specializing in the development and manufacturing of equipment for fast and accurate biosignal measurement. The company's core product lines include patient monitoring devices, automated external defibrillators (AEDs), pulse oximeters, and other emergency medical systems. Mediana serves a global market by offering its own branded products and providing Original Design Manufacturing (ODM) services. The company leverages software technology to enhance the functionality and user convenience of its medical solutions.

Recent filings

Filing Released Lang Actions
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Classification · 100% confidence The document is a 'Provisional Earnings Release' (영업(잠정)실적) for Mediana, detailing quarterly financial performance (Revenue, Operating Profit, Net Income) for the 3rd quarter of 2020. It provides key financial highlights and comparisons to previous periods, which is characteristic of an Earnings Release (ER). It is not a full report, but rather a summary announcement of financial results. Q3 2020
2020-10-26 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and specifically functions as a '정정신고' (Amendment Report) to a previously filed stock option grant. It details changes to the number of recipients and the total number of shares granted due to an employee's resignation. This type of filing is a standard regulatory disclosure regarding capital structure and employee compensation, which falls under the 'Regulatory Filings' category as it does not fit into specific categories like 'Director's Dealing' (which is for personal trades) or 'Share Issue' (which is for new capital issuance).
2020-10-26 Korean
기타경영사항(자율공시)(미국식품의약국(FDA) 의료기기 판매허가)
Regulatory Filings Classification · 95% confidence The document is a voluntary disclosure (자율공시) regarding the receipt of FDA approval for medical devices (Vital Sign Monitor V20, V20a, AVSM3 SNF). It is a regulatory announcement of a specific business event rather than a financial report, proxy, or shareholder meeting material. Since it does not fit into specific categories like M&A, dividends, or share transactions, it falls under the general regulatory filing category.
2020-10-21 Korean
기타경영사항(자율공시)(환자감시장치 M2000의 일본 후생노동성(MHLW) 승인)
Regulatory Filings Classification · 95% confidence The document is a regulatory disclosure (voluntary disclosure) from Mediana regarding the Japanese Ministry of Health, Labour and Welfare (MHLW) approval of their patient monitor product, M2000. It does not fit into specific categories like financial reports, board changes, or share transactions. As it is a general regulatory announcement regarding business operations/product approval, it falls under the RNS (Regulatory Filings) category.
2020-10-05 Korean
기타경영사항(자율공시)(감염관리를 대비한 원격조정 및 심장충격기와 융합된 자동 흉부압박기 개발과 임상적 유용성 평가(국책과제 선정))
Regulatory Filings Classification · 95% confidence The document is a voluntary disclosure ('자율공시') by Mediana regarding the selection of a government-funded research project ('국책과제 선정'). It details the project title, research period, budget, and expected outcomes. Since this is a specific corporate announcement regarding business operations and R&D activities that does not fit into financial reporting, M&A, or other specific categories, it is classified as a general regulatory filing.
2020-09-28 Korean
[기재정정]기타경영사항(자율공시)(국책과제선정(인공지능 기반 중증악화 예측 가능한 고성능 환자감시장치 시스템 개발))
Regulatory Filings Classification · 95% confidence The document is a regulatory filing from a Korean company (Mediana) regarding a 'voluntary disclosure' (자율공시) of a government-funded research project. It details the selection of the company for a national medical device development project, including project duration, budget, and objectives. Since this is a specific corporate announcement regarding business operations that does not fit into categories like financial reports, dividends, or M&A, it falls under the general regulatory filing category.
2020-09-09 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.